Catherine A. Sohn - 23 Mar 2023 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role
Director
Signature
/s/ Richard Eisenstadt, as Attorney-in-Fact
Issuer symbol
ALT
Transactions as of
23 Mar 2023
Net transactions value
$0
Form type
4
Filing time
27 Mar 2023, 16:17:02 UTC
Previous filing
09 Aug 2022
Next filing
15 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALT Stock Options (option to buy) Award $0 +47,000 $0.000000 47,000 23 Mar 2023 Common Stock, par value $0.0001 47,000 $4.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option become vested and exercisable in 36 substantially equal monthly installments following March 23, 2023, subject to the reporting person's continued service through the applicable vesting